[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"reactive-hyperemia\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:reactive-hyperemia":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":26,"conditions":27,"keywords":31,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":4},"100571649","phase-2-effect-of-olive-leaf-extracts-on-endothelial-dysfunction-in-patients-with-acute-coronary-syndrome-100571649",false,"NCT06723002","Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome","Effect of Olive Leaf Extracts on Endothelial Dysfunction and Short-term Outcome in Patients With Acute Coronary Syndrome","ACS_ATHEROLIV","Inclusion Criteria:\n\nAge over 18 years. Patients presenting with ST-segment alterations at rest, including ST elevation, with or without troponin elevation.\n\nPatients who have not undergone surgery or have no additional primary percutaneous coronary intervention (P-PCI) planned within 8 weeks from the initial P-PCI.\n\nPatients who provide informed consent. Patients available for and willing to adhere to follow-up procedures. Patients without significant cognitive impairment. Patients with a life expectancy of at least 2 years.\n\nExclusion Criteria:\n\n* Severe LV hypertrophy (\\>15 mm);\n* Patients with any evidence of inflammatory or malignant disease.\n* Patient having valvular heart disease, pacemaker; cardiogenic shock\n* Patient having any serious non-cardiac disease associated with a life expectancy \\\u003C1 year\n* Patients undergoing surgery within 30 days\n* Patient having gastrointestinal disorder such as Crohn's disease","ALL","18 Years",{"count":20,"type":21},300,"ESTIMATED","INTERVENTIONAL",[24,25],"PHASE2","PHASE3","the study aims to examine the short-term (30 days) effects of olive leaf extract on endothelial function in patients with acute coronary syndrome (ACS).\n\nThis investigation will be conducted on patients admitted to the emergency department for ACS. All participants will be screened and included within 24 hours post-ACS event and prior to discharge from the emergency department.",[28,29,30],"Acute Coronary Syndrome (ACS)","Reactive Hyperemia","Endothelial Dysfunction",[32,33,34],"acute conary syndrome","endothelial dysfunction","olive leaf extract","NOT_YET_RECRUITING","2024-12-03",{"date":38,"type":39},"2024-12-09","ACTUAL",{"date":41,"type":21},"2024-12-01",{"date":43,"type":21},"2025-12-30",{"name":45,"class":46},"University of Monastir","OTHER"]